These lifestyle factors are not genetic but are highly variable between individuals
Most importantly, be patient as your transformation takes time
One year after the start of the treatment, researchers found that the average weight reduction was 3.6% among the participants who discontinued their treatment early, compared to 6.8% for those who discontinued their treatment late
Why is FDA approval important
Meanwhile, a separate clinical trial, also published in the New England Journal of Medicine, found participants taking tirzepatide -- the active ingredient in Zepbound -- lost up to 22.5% of their body weight over 72 weeks
Semaglutide mimics the GLP-1 hormone to slow digestion and signal fullness to the brain, significantly reducing daily caloric intake